Finance

Beta
Lists
002422:SHE
Sichuan Kelun Pharmaceutical Co Ltd
CN¥34.61
+2.15%
(+0.73) 1D
Jun 5, 3:04:27 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002422...
Open
CN¥34.18
High
CN¥35.63
Low
CN¥34.18
Mkt. cap
53.90B
Avg. vol.
17.74M
Volume
17.42M
Dividend
1.72%
Quarterly dividend
CN¥0.15
Ex-dividend date
May 11, 2026
P/E ratio
34.78
52-wk high
CN¥41.72
52-wk low
CN¥28.14
EPS
CN¥1.00
Shares outstanding
1.59B
No. of employees
20K
Open
CN¥34.18
High
CN¥35.63
Low
CN¥34.18
Mkt. cap
53.90B
Avg. vol.
17.74M
Volume
17.42M
Dividend
1.72%
Quarterly dividend
CN¥0.15
Ex-dividend date
May 11, 2026
P/E ratio
34.78
52-wk high
CN¥41.72
52-wk low
CN¥28.14
EPS
CN¥1.00
Shares outstanding
1.59B
No. of employees
20K
News stories
From sources across the web
About Sichuan Kelun Pharmaceutical Co Ltd
CEO-
Employees20.1K
Founded1996
Headquarters-
SectorPharmaceutical industry
Websitekelun.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.69B
4.19B
5.24B
4.26B
Cost of goods sold
2.38B
2.29B
2.85B
2.33B
Cost of revenue
2.38B
2.29B
2.85B
2.33B
Research and development expenses
564.04M
584.41M
572.64M
586.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.12B
1.03B
1.17B
992.40M
Operating expense
1.71B
1.51B
1.97B
1.66B
Total operating expenses
4.09B
3.80B
4.82B
3.99B
Operating income
603.47M
390.58M
416.66M
271.42M
Other non operating income
6.36M
-139.75M
146.54M
82.48M
EBT including unusual items
644.46M
231.28M
754.91M
441.05M
EBT excluding unusual items
665.20M
292.43M
562.20M
407.20M
Income tax expense
190.20M
100.37M
122.46M
-31.65M
Effective tax rate
29.51%
43.40%
16.22%
-7.18%
Other operating expenses
6.43M
-103.78M
233.64M
66.32M
Net income
416.38M
200.04M
501.27M
453.70M
Net profit margin
8.87%
4.77%
9.57%
10.65%
Earnings per share
-
-
-
-
Interest and investment income
81.94M
72.25M
63.65M
76.41M
Interest expense
-27.23M
-29.99M
-19.09M
-23.12M
Net interest expenses
54.71M
42.26M
44.56M
53.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
925.53M
691.68M
739.75M
594.51M
Gain or loss from assets sale
-3.30M
3.30M
-5.32M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer